Seller Uriach Group
Target Uriach Group
Deal Type Mergers & Acquisitions
Buyer Fernandez y Canivell SA
Transaction Description

The Buyer, Uriach, is a Spain-based family-owned pharmaceutical group that closed 2019 with revenue of EUR 228m, 16% more than the previous year, and an EBITDA of EUR 46m. The pharmaceutical company expects turnover of EUR 300m in 2022.

Industry Sector
ICFG Office

ICFG Spain acted as exclusive Financial Adviser to Fernandez y Canivell SA in its divestment of its Ceregumil brand to Spanish Pharma Uriach Group.

Transaction Details

Boltendahl International Partners was hired as exclusive Financial Advisor to Fernandez y Canivell SA for its divestment of its iconic “Ceregumil” healthcare brand and other assets to the pharmaceutical group Uriach in Spain.